Literature DB >> 15868913

Urinary trypsin inhibitor suppresses surgical stress-facilitated lung metastasis of murine colon 26-L5 carcinoma cells.

Isaku Yoshioka1, Yasunori Tsuchiya, Yasushi Aozuka, Yasuharu Onishi, Hiroaki Sakurai, Keiichi Koizumi, Kazuhiro Tsukada, Ikuo Saiki.   

Abstract

Recently, we have reported that surgical stress promoted the metastasis of murine colon carcinoma cells to the lung by inducing the expression of proteases such as matrix metalloprotease-9 (MMP-9) in lung tissue. Urinary trypsin inhibitor (UTI) is a serine protease inhibitor frequently used to treat pancreatitis and to improve the microcirculatory environment. The purpose of this study was to investigate the anti-metastatic properties of UTI in an animal model of surgical stress-induced cancer metastasis. The intraperitoneal administration of UTI after the intravenous injection of colon 26-L5 carcinoma (colon 26-L5) cells into mice subjected to surgical stress suppressed the enhancement of lung metastasis (p<0.05). Furthermore, we investigated the effect of UTI on tumor growth, adhesion to fibronectin, migration, invasion and enzymatic degradation in colon 26-L5. UTI reduced the invasive ability and the degradation by MMP-9 of gelatin substrate in colon 26-L5 cells. UTI may improve therapeutic efficacy in cancer patients after major surgery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15868913

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Ulinastatin reduces the resistance of liver cancer cells to epirubicin by inhibiting autophagy.

Authors:  Bin Song; Qi Bian; Cheng Hao Shao; Gang Li; An An Liu; Wei Jing; Rui Liu; Yi-Jie Zhang; Ying-Qi Zhou; Xian-Gui Hu; Gang Jin
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

2.  Glucose regulated protein 78 promotes cell invasion via regulation of uPA production and secretion in colon cancer cells.

Authors:  Zongwei Li; Lichao Zhang; Hanqing Li; Shuhua Shan; Zhuoyu Li
Journal:  BMB Rep       Date:  2014-08       Impact factor: 4.778

3.  Ulinastatin reduces cancer recurrence after resection of hepatic metastases from colon cancer by inhibiting MMP-9 activation via the antifibrinolytic pathway.

Authors:  Bo Xu; Kun-Ping Li; Fei Shen; Huan-Qing Xiao; Wen-Song Cai; Jiang-Lin Li; Qi-Cai Liu; Lin Jia
Journal:  Biomed Res Int       Date:  2013-04-23       Impact factor: 3.411

4.  Synergism from the combination of ulinastatin and curcumin offers greater inhibition against colorectal cancer liver metastases via modulating matrix metalloproteinase-9 and E-cadherin expression.

Authors:  Fei Shen; Wen-Song Cai; Jiang-Lin Li; Zhe Feng; Qi-Cai Liu; Huan-Qing Xiao; Jie Cao; Bo Xu
Journal:  Onco Targets Ther       Date:  2014-02-18       Impact factor: 4.147

5.  The synergistic effect of propofol and ulinastatin suppressed the viability of the human lung adenocarcinoma epithelial A549 cell line.

Authors:  Ping Li; Peipei Guo; Chunshui Lin; Murong He; Xiaoqing Zhu; Chuan Liu; Jing Tang; Wei Wang; Weidong Liang
Journal:  Oncol Lett       Date:  2018-08-08       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.